-0.3 C
Wednesday, January 26, 2022

Wardha co’s Remdesivir to be in market in two weeks, Health News, ET HealthWorld

Must read


Nagpur: Wardha co’s Remdesivir to be in market in two weeksNagpur: Genetek Lifesciences has started the process of manufacturing Remdesivir injections at its MIDC Sewagram factory in Wardha district after Food and Drug Administration (FDA) cleared its loan licence from Hetero Labs Ltd.

The pharma company, owned by Mahendra Kshirsagar, is expected to start the market release of the drug in another two to three weeks with an optimum production of around 30,000 vials per day.

US-based Gilead Sciences had licensing agreement with seven Indian pharmaceutical companies including Hetero Labs to produce Remdesivir.

Genetek, which already produces several life-saving drugs, was granted FDA permission following the initiative of Union minister Nitin Gadkari. The proposal of Genetek to manufacture the anti-viral drug was also cleared by the drugs controller general of India earlier.

Chetan Marwah, principal correspondent of Genetek, said, “We have started procurement of raw materials, active and inactive ingredients from parent company.”

“The vials, the printing of the packages and labels too has started,” said Marwah claiming that the entire machinery was geared up for the production. “It will take around a fortnight or so to launch the product in the market. In mock runs, the production capacity may fluctuate but in the long run it would 30,000 per day. The drug would be released in the market through proper channel,” he said.

Marwah also said there would be no compromise on quality though some of the lengthier processes are likely to be shortened for a quicker release of the drugs needed to fight the pandemic. “The drug would be put through all necessary and mandatory tests and trials before release,” he said.


Source link

- Advertisement -spot_img

More articles


Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest article